Furthermore, CD10+GPR77+ CAFs could lead to successful engraftment of patient-derived xenografts (PDXs), while blocking these CAFs with a neutralizing anti-GPR77 antibody inhibited tumor formation while restoring chemosensitivity of the tumor. Here, MME is linked to neoplasm.